Motley Fool Money cover image

China, India, and the Question of Population Growth

Motley Fool Money

Type Two Diabetes - Is Continuous Glucose Monitoring a Good Option?

2min Snip

00:00
Play full episode
The majority of our system users have come from those who have type one or type two diabetes. About 50% of people in that category in the US use continuous glucose monitoring. Recently, CMS expanded CGM coverage for those who take any insulin. And that should double the size of that addressable market in the US ultimately to about seven and eight million individuals.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode